🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/03/2021 | 71,15 | 72,00 | 70,73 | 70,74 | -0,04% | 1,78% | 14.189.920 |
| 08/03/2021 | 70,96 | 72,10 | 70,04 | 70,77 | +1,42% | 2,90% | 15.391.347 |
| 05/03/2021 | 69,19 | 70,05 | 68,71 | 69,78 | +1,33% | 1,93% | 12.241.164 |
| 04/03/2021 | 69,83 | 69,96 | 68,44 | 68,86 | -1,54% | 2,19% | 15.975.188 |
| 03/03/2021 | 69,48 | 70,35 | 69,10 | 69,94 | +0,62% | 1,80% | 13.939.972 |
| 02/03/2021 | 69,50 | 70,12 | 69,08 | 69,51 | +0,65% | 1,50% | 16.047.290 |
| 01/03/2021 | 69,86 | 70,03 | 68,87 | 69,06 | -0,33% | 1,65% | 12.594.864 |
| 26/02/2021 | 71,03 | 71,29 | 69,22 | 69,29 | -2,68% | 2,92% | 17.644.862 |
| 25/02/2021 | 70,81 | 71,56 | 70,69 | 71,20 | +0,07% | 1,24% | 10.906.955 |
| 24/02/2021 | 71,37 | 71,82 | 70,98 | 71,15 | +0,04% | 1,18% | 9.838.834 |
| 23/02/2021 | 71,84 | 72,48 | 71,05 | 71,13 | -0,52% | 1,99% | 10.900.458 |
| 22/02/2021 | 71,09 | 71,62 | 70,35 | 71,50 | +0,83% | 1,79% | 8.612.464 |
| 19/02/2021 | 71,98 | 72,05 | 70,86 | 70,91 | -1,46% | 1,66% | 12.388.198 |
| 18/02/2021 | 71,82 | 72,40 | 71,60 | 71,96 | -0,17% | 1,12% | 10.004.627 |
| 17/02/2021 | 71,05 | 72,58 | 70,96 | 72,08 | +1,74% | 2,27% | 13.876.463 |
| 16/02/2021 | 71,92 | 71,98 | 70,66 | 70,85 | -1,00% | 1,83% | 9.734.453 |
| 12/02/2021 | 71,30 | 71,67 | 71,13 | 71,56 | +0,35% | 0,76% | 6.738.116 |
| 11/02/2021 | 71,38 | 71,66 | 70,83 | 71,32 | -0,20% | 1,16% | 8.780.982 |
| 10/02/2021 | 71,87 | 71,93 | 71,13 | 71,46 | -0,20% | 1,12% | 11.721.566 |
| 09/02/2021 | 71,66 | 71,73 | 70,95 | 71,60 | +0,00% | 1,08% | 13.484.616 |
| 08/02/2021 | 72,38 | 72,70 | 71,24 | 71,60 | -1,00% | 2,02% | 16.718.534 |
| 05/02/2021 | 72,93 | 73,45 | 71,96 | 72,33 | -0,30% | 2,05% | 13.901.825 |
| 04/02/2021 | 73,44 | 73,48 | 72,08 | 72,55 | -1,67% | 1,91% | 18.867.563 |
| 03/02/2021 | 74,08 | 74,57 | 73,62 | 73,78 | -0,58% | 1,29% | 10.034.810 |
| 02/02/2021 | 74,23 | 75,31 | 74,14 | 74,21 | +0,53% | 1,57% | 9.866.710 |
| 01/02/2021 | 74,42 | 74,74 | 73,80 | 73,82 | +0,38% | 1,27% | 8.224.599 |
| 29/01/2021 | 74,42 | 74,78 | 72,89 | 73,54 | -1,09% | 2,54% | 10.671.470 |
| 28/01/2021 | 73,55 | 74,91 | 73,54 | 74,35 | +1,10% | 1,87% | 12.972.039 |
| 27/01/2021 | 76,20 | 76,40 | 73,32 | 73,54 | -3,96% | 4,04% | 16.230.376 |
| 26/01/2021 | 77,43 | 77,43 | 76,46 | 76,57 | -1,11% | 1,26% | 7.748.283 |